Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-259-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity studies for read-across substances are available by oral and dermal routes of administration. The acute inhalation study was not considered necessary and no read -across data were available for this route of exposure. Oral administration of octyl steartae to rats elicited no signs of toxicity up to a dose of 8000 mg/kg bw. Oral dosing with ethyl hexyl palmitate also resulted in a median lethal dose that exceed the limit of 5 g/kg bw. The dermal toxicity investigated in rabbits for the analogous material, ethylhexyl palmitate, resulted in a median lethal dose that exceeded the 5 g/kg bw limit.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- February 1978
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: A single page summary of the study results is available but insufficient details are present to assess the study reliability accurately
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Standard single dose gavage assay
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: No data
- Age at study initiation: No data
- Weight at study initiation: No data
- Fasting period before study: No data
- Housing: No data
- Diet (e.g. ad libitum): No data
- Water (e.g. ad libitum): No data
- Acclimation period: No data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): No information in study report
- Humidity (%):No information in study report
- Air changes (per hr):No information in study report
- Photoperiod (hrs dark / hrs light):No information in study report
IN-LIFE DATES: From: To:No information in study report - Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: Not specified
- Doses:
- 5 g/kg bw
- No. of animals per sex per dose:
- 10 rats
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: No data
- Frequency of observations and weighing: No data
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- No information - as a limit test no statistical analysis is required
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No deaths ina group of ten rats dosed at 5 g/kg
- Mortality:
- No deaths occurred in a group of ten rats administered a dose of 5g ethylhexyl palmitate/kg bw.
- Clinical signs:
- other: piloerection and a wet anogenital region were observed butthe incidence or persistence of these signs is not specified. No indication is given related to recovery.
- Gross pathology:
- Eight rats were considered normal, macroscopic examination revealed a dark liver for one rat, dark areas on the lungs of one rat and dark kidneys in one case.
- Other findings:
- None identified
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- No deaths occurred in a group of ten ratsdosed at 5g/kg with ethylhexyl palmitate. On basis of read across toa similar material, no acute toxicity is anticipated for fatty acids, C12-2- and C12-20 unsaturated, 2-ethylhexyl esters and no classification for acute oral hazard isrequired according to CLP.
- Executive summary:
No deaths occurred in a group of ten rats dosed at 5 g/kg with ethylhexyl palmitate. On basis of read across toa similar material, no acute toxicity is anticipated for fatty acids, C12-2- and C12-20 unsaturated, 2-ethylhexyl esters and no classification for acute oral hazard isrequired according to the CLP Regulation.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- Not stated
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Limited information summarised in a public domain paper, no details of methods, models or guidelines followed.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- A limit test determination of acute oral LD50 was conducted in rats
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- No data
- Doses:
- 5g/kg
- No. of animals per sex per dose:
- Not specified
- Control animals:
- not specified
- Details on study design:
- No details provided - oral administration of the limit dose to rats
- Statistics:
- No information - not required for a limit test
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No information in public summary of study report
- Clinical signs:
- other: No information in public summary of study report
- Gross pathology:
- No information in public summary of study report
- Other findings:
- No information in public summary of study report
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral LD50 was greater than 5g/kg for ethylhexyl palmitate in rats. On this basis, by read across to similar material, no classification is required for oral toxicity hazard of fatty acids, C12-20 and C12-20 unsaturated, 2-ethylhexyl esters according to CLP.
- Executive summary:
The acute oral LD50 for ethyl hexyl palmitate was greater than 5 g/kg in rats; no classification is required for oral toxicity hazard of fatty acids, C12-20 and C12-20 unsaturated, 2-ethylhexyl esters according to CLP.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- not stated
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Peer-reviewed review of several safety assessments
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The standard acute oral study design was used - five males and five females dosed at 8000 mg/kg bw by oral gavage and then observed for 14 days, with bodyweights recorded in life
- GLP compliance:
- no
- Test type:
- other: various investigations are reported by various methods for a range of stearates
- Limit test:
- yes
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No details provided in report
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: not applicable - administered as supplied
MAXIMUM DOSE VOLUME APPLIED: 8 mL/kg bw - Doses:
- 8.0 g/kg bw
- No. of animals per sex per dose:
- five males and five females
- Control animals:
- no
- Details on study design:
- Undiluted Octyl Stearate was administered to 5 male and 5 female rats at oral doses of 8.0 ml/kg. No further details provided.
- Statistics:
- No statistical analysis required
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 8 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths in a group of ten treated rats
- Clinical signs:
- other: No clinical signs of reaction to treatment reported
- Gross pathology:
- No information
- Other findings:
- No additional details
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In a group of five male and five female rats exposed by oral gavage to a dose of 8 g/kg bw of octyl stearate, there were no adverse toxic effects. The median lethal dose exceeded the limit dose level for octyl stearate and by read-across no classification for oral toxicity is necessary for fatty acids C12-20 and C12-20 unsaturated, 2-ethylhexyl ester
- Executive summary:
In a group of five male and five female rats exposed by oral gavage to a dose of 8 g/kg bw of octyl stearate, there were no adverse toxic effects. The median lethal dose exceeded the limit dose level for octyl stearate and by read-across no classification for oral toxicity is necessary for fatty acids C12-20 and C12-20 unsaturated, 2-ethylhexyl ester
Referenceopen allclose all
No information in public summary of study report
No additional details
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- February 1978
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: A single page summary of the study results is available but insufficient details are present to assess the study reliability accurately
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Standard single dose dermal application
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: No data
- Age at study initiation: No data
- Weight at study initiation: No data
- Fasting period before study: No data
- Housing: No data
- Diet (e.g. ad libitum): No data
- Water (e.g. ad libitum): No data
- Acclimation period: No data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): No information in study report
- Humidity (%):No information in study report
- Air changes (per hr):No information in study report
- Photoperiod (hrs dark / hrs light):No information in study report
IN-LIFE DATES: From: To:No information in study report - Type of coverage:
- not specified
- Vehicle:
- not specified
- Details on dermal exposure:
- Ne details provided in report
- Duration of exposure:
- No data
- Doses:
- 5g/kg bw
- No. of animals per sex per dose:
- 10 rabbits in total
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: No data
- Frequency of observations and weighing: No data
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- No information - as a limit test no statistical analysis is required
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No deaths in a group of ten rats dosed at 5 g/kg
- Mortality:
- No deaths occurred in a group of ten rabbits administered a dose of 5g ethylhexyl palmitate/kg bw.
- Clinical signs:
- other: No clinical signs were recorded for any of the treated rabbits.
- Gross pathology:
- Necropsy revealed several macropscopic changes including :
brown anogenital exudate - 2 rabbits
Intestines, red areas - 3 rabbits; yellow areas - 1 rabbit; bloated - 1 rabbit
Liver, dark - 6 rabbits, mottled appearance - 1 rabbit; white nodules - 1 rabbit.
Dark areas on lungs - 2 rabbits - Other findings:
- Nine of the ten rabbits developed slight or moderate erythema and 9/10 also had slight oedema formation.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- No deaths occurred in a group of ten rabbits dosed topically at 5g/kg with ethylhexyl palmitate. On basis of read across toa similar material, no acute dermal toxicity is anticipated for fatty acids, C12-2- and C12-20 unsaturated, 2-ethylhexyl esters and no classification for acute dermal hazard is required according to the CLP Regulation.
- Executive summary:
No deaths occurred in a group of ten rabbits dosed topically at 5g/kg with ethylhexyl palmitate. On basis of read across toa similar material, no acute dermal toxicity is anticipated for fatty acids, C12-2- and C12-20 unsaturated, 2-ethylhexyl esters and no classification for acute dermal hazard is required according to the CLP Regulation.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- not stated
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Limited information summarised in a public domain paper, no details of methods, models or guidelines followed.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- A limit test determination of acute dermal LD50 was conducted in rabbits
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Details on dermal exposure:
- No data
- Duration of exposure:
- No data
- Doses:
- 5 g/kg bw
- No. of animals per sex per dose:
- 10 rabbits
- Control animals:
- not specified
- Details on study design:
- No details provided - dermal application of the limit dose to rabbits
- Statistics:
- No information - not required for a limit test
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No information in public summary of study report
- Clinical signs:
- other: No information in public summary of study report
- Gross pathology:
- No information in public summary of study report
- Other findings:
- No information in public summary of study report
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute dermal LD50 was greater than 5g/kg for ethylhexyl palmitate in rabbits. On this basis, by read across to similar material, no classification is required for dermal toxicity hazard of fatty acids, C12-20 and C12-20 unsaturated, 2-ethylhexyl esters according to the CLP Regulation
- Executive summary:
The acute dermal LD50 was greater than 5g/kg for ethylhexyl palmitate in rabbits. On this basis, by read across to similar material, no classification is required for dermal toxicity hazard of fatty acids, C12-20 and C12-20 unsaturated, 2-ethylhexyl esters according to the CLP Regulation
Referenceopen allclose all
No information in public summary of study report
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 8 000 mg/kg bw
Additional information
Acute studies were available by oral and dermal routes of administration. The acute inhalation study was not considered necessary and no read -across data were available for this route of exposure. Oral administration of octyl stearate to rats elicited no signs of toxicity up to a dose of 8000 mg/kg bw. Oral dosing with ethyl hexyl palmitate also resulted in a median lethal dose that exceed the limit of 5 g/kg. The dermal toxicity investigated in rabbits for the analogous material , ethylhexyl palmitate, resulted in a median lethal dose that exceeded the 5 g/kg limit.
Justification for classification or non-classification
Acute toxicity studies conducted with read-across substances do not trigger classification for acute toxicity according to the CLP Regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.